EDVINCE
LIVE

Serial Number

79430938

Owner

Edvince AB

Attorney

Bradley M. Stohry

Filing Date

Jul 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EDVINCE Trademark

Serial Number: 79430938

EDVINCE is a trademark filed by Edvince AB on July 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Edvince AB (2 trademarks)

Medicon Village
SE-223 81 Lund , SE

Entity Type: 99

Trademark Details

Filing Date

July 30, 2025

Registration Date

Not Registered

Published for Opposition

May 19, 2026

Goods & Services

Scientific and technological services, namely, scientific research, in the field of developing methods for the treatment, prevention and alleviation of stroke; industrial analysis and research in the field of development methods for treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia; basic research and clinical research in the field of development of medicaments

Preparations for pharmaceutical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical preparations for pharmaceutical or medical purposes, namely, for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); diagnostic preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical reagents for medical purposes; preparations for analysis for medical purposes, namely, for the treatment of ischemic disorders and diseases, stroke and subarachnoid hemorrhage and delayed cerebral ischemia (DCI)

Filing History

NOTIFICATION PROCESSED BY IB
May 21, 2026 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 29, 2026 OP2R
REFUSAL PROCESSED BY IB
Apr 23, 2026 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 1, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 1, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 30, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 17, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 21, 2025 SDRC